Search
for
Sort by
Research 391–420 of 1000+
- 5-alpha Reductase inhibitors and risk of male breast cancer: a systematic review and meta-analysis
- Re: Risk of Erectile Dysfunction Associated with Use of 5α-Reductase Inhibitors for Benign Prostatic Hyperplasia or Alopecia: Population Based Studies Using the Clinical Practice Research Datalink
- Five-Alpha Reductase Inhibitor and Breast Cancer Risk in Men: A Systematic Review
- Association of long-term 5α-reductase inhibitor use with survival in men with renal cell carcinoma: a nationwide population-based cohort study
- The Association Between 5α-Reductase Inhibitors and the Presence of Subsequent Dry Eye Disease in Androgenetic Alopecia: A TriNetX Database Study
- Comparative Efficacy Evaluation of Alopecia Areata Management with Janus Kinase Inhibitors in Children: Retrospective Cohort Study
- Optimal concentration selection of active pharmaceutical ingredients in the cream-mask intended for androgenic alopecia treatment according to experimental results on paramecium caudatum biological model
- ATP-competitive mTOR kinase inhibitors delay plant growth by triggering early differentiation of meristematic cells but no developmental patterning change
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Synthesis of phenanthridin-3-one derivatives: Non-steroidal inhibitors of steroid 5-α-reductase
- Anti-androgenic curcumin analogues as steroid 5-alpha reductase inhibitors
- The effect of finasteride, a 5 alpha-reductase inhibitor, on scalp skin testosterone and dihydrotestosterone concentrations in patients with male pattern baldness.
- Effects of PNU157706, a Dual 5α-Reductase Inhibitor, on Rat Epididymal Sperm Maturation and Fertility1
- Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis
- Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function
- Three-Dimensional Proteome-Wide Scale Screening for the 5-Alpha Reductase Inhibitor Finasteride: Identification of a Novel Off-Target
- Effects of 5-alpha reductase inhibitors
- Analysis of Data From Breast Diseases Treated With 5-Alpha Reductase Inhibitors for Benign Prostatic Hyperplasia
- The Identification of multi-target Inhibitors of Wolbachia pipientis and Onchocerca volvulus by molecular simulations
- Risk of Type 2 Diabetes Mellitus in New Users of 5-Alpha Reductase Inhibitors: A Nationwide Historical Cohort Study
- Do Alpha-Blockers and 5-Alpha Reductase Inhibitors Increase Dementia Risk? A Network Meta-analysis
- Novel type 1 5a-reductase Inhibitors with Antiproliferative Potential on LNCaP cells
- 5-alpha reductase inhibitors: New evidences on benefits and harms beyond benign prostatic hyperplasia
- Field Cancerization: From Molecular Basis to Selective Field-Directed Management of Actinic Keratosis
- Effects of the selective TrkA agonist gambogic amide on pigmentation and growth of human hair follicles in vitro
- APCDD1 is a novel Wnt inhibitor mutated in hereditary hypotrichosis simplex
- Age-associated inflammation inhibits epidermal stem cell function
- Side Effects of 5‐Alpha Reductase Inhibitors: A Comprehensive Review
- Investigation of the Plausibility of 5-Alpha-Reductase Inhibitor Syndrome
- Male Breast Cancer and 5α-Reductase Inhibitors Finasteride and Dutasteride